These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1378308)

  • 21. Renal osteodystrophy in patients on hemodialysis for more than 10 years.
    Piraino BM; Rault R; Dominguez JH; Puschett JB
    Miner Electrolyte Metab; 1986; 12(5-6):390-6. PubMed ID: 3807834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2000; 20(4):362-72. PubMed ID: 11039262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Renal osteodystrophy in Maracaibo].
    Salgado O; García R; Delling G; Navarro J; Romero RA; Rodríguez-Iturbe B
    Invest Clin; 1992; 33(4):153-64. PubMed ID: 1303675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine?
    Hodsman AB; Hood SA; Brown P; Cordy PE
    J Lab Clin Med; 1985 Dec; 106(6):674-81. PubMed ID: 4067379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization.
    Cournot-Witmer G; Zingraff J; Plachot JJ; Escaig F; Lefèvre R; Boumati P; Bourdeau A; Garabédian M; Galle P; Bourdon R; Drüeke T; Balsan S
    Kidney Int; 1981 Sep; 20(3):375-8. PubMed ID: 7300127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased bone strontium levels in hemodialysis patients with osteomalacia.
    D'Haese PC; Schrooten I; Goodman WG; Cabrera WE; Lamberts LV; Elseviers MM; Couttenye MM; De Broe ME
    Kidney Int; 2000 Mar; 57(3):1107-14. PubMed ID: 10720963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The spectrum of bone disease in 200 chronic hemodialysis patients: a correlation between clinical, biochemical and histological findings.
    Duarte ME; Peixoto AL; Pacheco AS; Peixoto AV; Rodriguez RD; Lugon JR; Cruz EA
    Sao Paulo Med J; 1998; 116(5):1790-7. PubMed ID: 10030103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
    Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive diagnosis of uremic osteodystrophy: uses and limitations.
    Heaf JG; Joffe P; Pødenphant J; Andersen JR
    Am J Nephrol; 1987; 7(3):203-11. PubMed ID: 3631150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aluminum in renal osteodystrophy].
    Zhu P; Wang GY; Yu YF; Zhu P
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):176-8. PubMed ID: 8222983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].
    Cournot-Witmer G; Gagnadoux MF; Lebon P; Broyer M; Balsan S
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():749-54. PubMed ID: 6762177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy.
    Ott SM; Maloney NA; Coburn JW; Alfrey AC; Sherrard DJ
    N Engl J Med; 1982 Sep; 307(12):709-13. PubMed ID: 6896740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients.
    Faugere MC; Malluche HH
    Kidney Int; 1986 Nov; 30(5):717-22. PubMed ID: 2431192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy.
    Milliner DS; Nebeker HG; Ott SM; Andress DL; Sherrard DJ; Alfrey AC; Slatopolsky EA; Coburn JW
    Ann Intern Med; 1984 Dec; 101(6):775-9. PubMed ID: 6208838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.
    Fletcher S; Jones RG; Rayner HC; Harnden P; Hordon LD; Aaron JE; Oldroyd B; Brownjohn AM; Turney JH; Smith MA
    Nephron; 1997; 75(4):412-9. PubMed ID: 9127327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A sensitive stain for aluminum in undecalcified cancellous bone.
    Walton JR; Diamond TH; Kumar S; Murrell GA
    J Inorg Biochem; 2007 Sep; 101(9):1285-90. PubMed ID: 17664014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated bone aluminum and suppressed parathyroid hormone levels in hypercalcemic dialysis patients.
    Piraino B; Chen T; Puschett JB
    Am J Nephrol; 1989; 9(3):190-7. PubMed ID: 2757078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy.
    Coburn JW; Brickman AS; Sherrard DJ; Singer FR; Wong EG; Baylink DJ; Norman AW
    Proc Eur Dial Transplant Assoc; 1977; 14():442-50. PubMed ID: 600961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Aluminum poisoning in renal dialysis patients: bone histology. Value of quantitative bone biopsy].
    Charhon SA; Chapuy MC; Traeger J; Meunier PJ
    Presse Med; 1984 Jun; 13(23):1431-4. PubMed ID: 6233588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High frequency of iron bone deposits in a Mexican population with renal osteodystrophy.
    Velásquez Forero F; Altamirano E; Ramos PT
    Nephrol Dial Transplant; 1998; 13 Suppl 3():46-50. PubMed ID: 9568820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.